CIK 0001623526 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 184.4 M | 8.8 M | 12.4 M | |
| Net income (USD) | -101.1 M | -85.8 M | ||
| Diluted EPS (USD/shares) | -0.12 | -2.38 | -2.6 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | 4 | 2026-10-02 |
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-02 | 144 | 144 | |
| 2026-09-30 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-25 | 4 | 4 | 2026-09-23 |
| 2026-09-25 | 3 | 3 | 2026-09-23 |
| 2026-09-25 | 8-K | 8-K items 5.02 | 2026-09-22 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-03 | 8-K | 8-K items 8.01,9.01 | 2026-08-03 |
| 2026-08-03 | 424B5 | 424B5 | |
| 2026-08-03 | 144 | 144 | |
| 2026-08-03 | S-8 | S-8 | |
| 2026-08-03 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-03 | 8-K | 8-K items 2.02,9.01 | 2026-08-03 |
| 2026-07-17 | 4 | 4 | 2026-07-16 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-17 | 3 | 3 | 2026-07-13 |
| 2026-07-06 | 4 | 4 | 2026-07-01 |
Forms on file (last 1,000): 4 275, 8-K 84, 144 47, 3 25, SC 13G/A 23, 10-Q 22, SCHEDULE 13G/A 21, SC 13G 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=STOK (0.002 USD), /gw/filings/filings?ticker=STOK&form=8-K, /gw/filings/facts?ticker=STOK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange